See full statistics
Total publications
15
Total citations
76
Citations per publication
5.07
Average publications per year
2.14
Average coauthors
11.87
Publications years
2018-2024 (7 years)
h-index
4
i10-index
2
m-index
0.57
o-index
12
g-index
8
w-index
1
Metrics description

Fields of science

1
2
3
Pharmacology, 3, 20%
Drug Discovery, 2, 13.33%
Molecular Medicine, 2, 13.33%
Infectious Diseases, 2, 13.33%
Pharmacology (medical), 2, 13.33%
General Chemistry, 1, 6.67%
Biochemistry, 1, 6.67%
Cell Biology, 1, 6.67%
Biophysics, 1, 6.67%
Pharmaceutical Science, 1, 6.67%
Microbiology, 1, 6.67%
Applied Microbiology and Biotechnology, 1, 6.67%
Parasitology, 1, 6.67%
1
2
3

Journals

1
1

Citing journals

1
2
3
4
Journal not defined, 4, 5.26%
Show all (22 more)
1
2
3
4

Publishers

1
2
3
1
2
3

Organizations from articles

1
2
3
4
5
6
7
Organization not defined, 7, 46.67%
1
2
3
4
5
6
7

Countries from articles

2
4
6
8
10
Country not defined, 10, 66.67%
Japan, 8, 53.33%
Indonesia, 7, 46.67%
Nigeria, 1, 6.67%
Switzerland, 1, 6.67%
2
4
6
8
10

Citing organizations

2
4
6
8
10
12
14
16
18
Organization not defined, 17, 22.37%
Show all (70 more)
2
4
6
8
10
12
14
16
18

Citing countries

5
10
15
20
25
Japan, 21, 27.63%
Country not defined, 16, 21.05%
Indonesia, 14, 18.42%
China, 12, 15.79%
India, 9, 11.84%
USA, 7, 9.21%
United Kingdom, 4, 5.26%
New Zealand, 4, 5.26%
Bangladesh, 3, 3.95%
Egypt, 3, 3.95%
Spain, 3, 3.95%
Germany, 2, 2.63%
Brazil, 2, 2.63%
Malaysia, 2, 2.63%
Nigeria, 2, 2.63%
Romania, 2, 2.63%
Saudi Arabia, 2, 2.63%
Thailand, 2, 2.63%
Switzerland, 2, 2.63%
Russia, 1, 1.32%
Ukraine, 1, 1.32%
Portugal, 1, 1.32%
Australia, 1, 1.32%
Belgium, 1, 1.32%
Italy, 1, 1.32%
Democratic Republic of the Congo, 1, 1.32%
Mexico, 1, 1.32%
Mongolia, 1, 1.32%
Norway, 1, 1.32%
Pakistan, 1, 1.32%
Poland, 1, 1.32%
Republic of Korea, 1, 1.32%
Tunisia, 1, 1.32%
Turkey, 1, 1.32%
Ecuador, 1, 1.32%
South Africa, 1, 1.32%
Show all (6 more)
5
10
15
20
25
  • We do not take into account publications without a DOI.
  • Statistics recalculated daily.